Changes to the Code
H.R. 5133 · Patients’ Right to Know Their Medication Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 352 Misbranded drugs and devices
+2 −0Shown
1 change the bill asks for here, 1 carried out
- Carried out:
Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:
(hh) If it is a drug subject to section 503(b)(1) and patient medication information is not provided in accordance with section 505H..
§ 352(gg)–(hh)
Start of § 352 to (gg)(2)(E) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (gg)(2)(F) | (F) | (F) | ||
| product-related programs or services; and | product-related programs or services; and | |||
| (gg)(2)(G) | (G) | (G) | ||
| factual presentations of results from studies that do not characterize or make conclusions regarding safety or efficacy. | factual presentations of results from studies that do not characterize or make conclusions regarding safety or efficacy. | |||
| (hh) | (hh) [inserted: ] | |||
| [inserted: If it is a drug subject to section 503(b)(1) and patient medication information is not provided in accordance with section 505H.] | ||||